Showing results (261-270 of 295) with videos related to

Sort By:
Pageof 30
Journal of Korean Medical Science|June 18, 2013
Risk factors for acute hepatitis A infection in Korea in 2007 and 2009: a case-control studyJoo Youn Seo, Bo Youl Choi, Moran Ki, et al.
Drug Safety|March 21, 2024
Angiotensin Receptor Blockers and the Risk of Suspected Drug-Induced Liver Injury: A Retrospective Cohort Study Using Electronic Health Record-Based Common Data Model in South KoreaHyunjoo Kim, Nayeong Son, Dahee Jeong, et al.
Journal of Gastroenterology|December 5, 2022
SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT ForumYoshihiro Kamada, Takahiro Nakamura, Satoko Isobe, et al.
Medicine|April 9, 2016
An Observational, Multicenter, Cohort Study Evaluating the Antiviral Efficacy and Safety in Korean Patients With Chronic Hepatitis B Receiving Pegylated Interferon-alpha 2a (Pegasys): TRACES StudyYoung Eun Chon, Dong Joon Kim, Sang Gyune Kim, et al.
Alimentary Pharmacology & Therapeutics|October 26, 2023
Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational studyEiichi Ogawa, Dae Won Jun, Hidenori Toyoda, et al.
Journal of Hepatology|September 21, 2023
PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis BHo Soo Chun, George V Papatheodoridis, Minjong Lee, et al.
The Lancet. Gastroenterology & Hepatology|March 24, 2019
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysisJie Li, Biyao Zou, Yee Hui Yeo, et al.
Cancers|June 10, 2023
Inverse Propensity Score-Weighted Analysis of Entecavir and Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B: A Large-Scale Multicenter StudyJihye Kim, Moon Haeng Hur, Seung Up Kim, et al.
Hepatology Communications|January 13, 2021
Effects of Cirrhosis and Diagnosis Scenario in Metabolic-Associated Fatty Liver Disease-Related Hepatocellular CarcinomaVincent L Chen, Ming-Lun Yeh, Ju Dong Yang, et al.
Clinical and Molecular Hepatology|July 10, 2013
Efficacy and safety of entecavir plus carnitine complex (GODEX®) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL studyDae Won Jun, Byung Ik Kim, Yong Kyun Cho, et al.
Pageof 30